A new screening tool for electronic medical records accurately identifies patients who are at high risk of having or developing progressive scarring of the lungs, a condition called idiopathic pulmonary fibrosis, according to investigators from Weill Cornell Medicine, NewYork-Presbyterian, the University of Chicago, Brigham and Women’s Hospital and Mayo Clinic.
Idiopathic pulmonary fibrosis (IPF) is usually fatal, in part because it tends to be diagnosed late in its course, when...
Read More